We further confirmed this classification by calculating the average expression of IGF2BP1, IGF2BP2, and IGF2BP3 across cancer types and clusters, which consistently showed the highest levels in IGF2BP-H, intermediate in IGF2BP-M, and lowest in IGF2BP-L (Table S1C). This evidence concerns the gene IGF2BP2 and cancer.